Innovent Biologics, Inc. (IVBXF)
12.20
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Innovent Biologics Price : 12.20 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 12.20 | 12.20 | 12.20 | 12.20 | 413.00 |
| Oct 05, 2026 | 12.20 | 12.20 | 12.20 | 12.20 | 5701.00 |
| Oct 02, 2026 | 12.80 | 12.80 | 12.80 | 12.80 | 396.00 |
| Oct 01, 2026 | 12.40 | 12.51 | 12.40 | 12.51 | 5703.00 |
| Sep 30, 2026 | 12.53 | 12.53 | 12.53 | 12.53 | 735.00 |
| Sep 29, 2026 | 13.36 | 13.36 | 13.36 | 13.36 | 601.00 |
| Sep 28, 2026 | 13.36 | 13.36 | 13.36 | 13.36 | 428.00 |
| Sep 25, 2026 | 12.45 | 12.45 | 12.45 | 12.45 | 561.00 |
| Sep 24, 2026 | 13.82 | 13.82 | 12.45 | 12.45 | 1411.00 |
| Sep 23, 2026 | 12.55 | 12.55 | 12.55 | 12.55 | 479.00 |
| Sep 22, 2026 | 14.25 | 14.25 | 14.25 | 14.25 | 1158.00 |
| Sep 21, 2026 | 14.65 | 14.65 | 12.53 | 12.53 | 1070.00 |
| Sep 18, 2026 | 12.36 | 12.36 | 12.36 | 12.36 | 467.00 |
| Sep 17, 2026 | 12.36 | 12.36 | 12.36 | 12.36 | 585.00 |
| Sep 16, 2026 | 11.01 | 11.01 | 11.01 | 11.01 | 781.00 |
| Sep 15, 2026 | 11.35 | 12.34 | 11.35 | 12.34 | 4086.00 |
| Sep 14, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 361.00 |
| Sep 11, 2026 | 11.01 | 12.31 | 11.01 | 11.76 | 1104.00 |
| Sep 10, 2026 | 12.36 | 12.36 | 12.00 | 12.00 | 777.00 |
| Sep 09, 2026 | 12.66 | 12.66 | 12.66 | 12.66 | 553.00 |
| Sep 08, 2026 | 13.18 | 13.18 | 13.18 | 13.18 | 6192.00 |
| Sep 04, 2026 | 13.00 | 13.11 | 13.00 | 13.11 | 4841.00 |
| Sep 03, 2026 | 12.84 | 12.84 | 12.84 | 12.84 | 145.00 |
| Sep 02, 2026 | 12.84 | 12.84 | 12.84 | 12.84 | 431.00 |
| Sep 01, 2026 | 13.99 | 13.99 | 12.84 | 12.84 | 1967.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 1.04 |
| CStone Pharmaceuticals Co. Ltd. | 0.7547 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.85 |
| Adagene, Inc. | 2.825 |
Price Related Metrics
| PE Ratio | 122.37 |
| PS Ratio | 9.583 |
| Price to Free Cash Flow | 11.76 |
| Earnings Yield | 0.82% |
| Market Cap | 21.21B |
| Operating PE Ratio | 56.73 |
| Normalized PE Ratio | 138.95 |